Chimera Investment (CIM) Tops Q4 EPS by 12c

Chimera Investment (NYSE: CIM) reported Q4 EPS of $0.64, $0.12 better than the analyst estimate of $0.52.

For earnings history and earnings-related data on Chimera Investment (CIM) click here.

You May Also Be Interested In

• Key things to know ahead of SK Hynix’s blockbuster US listing
• ImmuCell reports 11.5% sales rise in Q2 2026, 20.9% gain for first half
• Berenberg Downgrades Siemens Healthineers (SHL:GR) (SEMHF) to Hold